logo inner

VP, Biometrics


Cytokinetics is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle performance is compromised. As a leader in muscle biology and the mechanics of muscle performance, the company is developing small molecule drug candidates specifically engineered to impact myocardial muscle function and contractility.
At Cytokinetics, each team member plays an integral part in advancing our mission to improve the lives of patients. We are seeking tenacious, compassionate, and collaborative individuals who are driven to make a positive impact.The VP of Biometrics, reporting to SVP of Development Operations, will be the spoke person and responsible for successful strategic positioning and tactical advancement of Biometrics. This role is managing all Biometrics functions, including Biostatistics, Data Management, Statistical Programming, and Clinical Systems.

Supports the development/documentation of procedures and policies for the operations. Participates in establishing drug development strategy and direction. This executive role works closely with drug development partners and participates in strategizing and executing the clinical development programs with a strong technical, regulatory, and scientific foundation to define the most effective approach across Cytokinetics’ R&D pipeline.

Responsibilities 


  • Define and execute the strategic vision for the Biometrics Department.
  • Establish organizational structure for biometrics department, including Biostatistics, Statistical Programming, Data Management, and Clinical Systems functions. Lead and develop Biometrics employees.
  • Oversee and coordinate all biometrics activities to support of clinical development projects as well as deliver innovative study designs and analysis plans, ensuring sound biometrics principles and compliance with regulatory guidelines.
  • Advises on statistical issues associated with the design and analysis of clinical trials and responsible for biometrics input on all major documents including, clinical development plans, protocols, data collection methodologies, clinical study reports and summaries of clinical safety and efficacy for regulatory filings.
  • Guide application of epidemiologic methods to analyze observational/real world data to strengthen submission evidence and support drug development.
  • Provides review and guidance on statistical aspects, new programming, database technologies, clinical systems and standards of all FDA/EMEA regulations and ICH & GCP guidelines.
  • Senior biostatistics representative supports protocol/clinical document review, strategic- and partner joint- development activities, drug safety, and publication activities.
  • Collaborate with other senior development leaders ensure consistency of development work standards intellectually, challenging assumptions and sharing ideas.
  • Provide leadership for sponsor/CRO activities, relationships and escalation resolution.
  • Interact with FDA/EMA and other health authorities to ensure clinical studies meet regulatory requirements and to ensure ongoing agreement on project development.
  • Support the development and implementation of best practices, SOPs, standards, work instructions and policies for biostatistics.

Qualifications 


  • Ph.D. in Statistics or related fields and 15+ years of pharmaceutical industry experience or Master in Statistics and 20+ years of comparable experience
  • Expert knowledge of ICH and other regulatory development guidelines.
  • Experience in recruiting, coaching, and developing talented team members.
  • Deep understanding of mathematical and statistical principles; demonstrated proficiency in at least one statistical analysis software (SAS preferably). Knowledge of other statistical software is a plus.
  • Experience in clinical development of wide range of therapeutic areas is a plus.
  • Stellar communication and presentation skills. Must be able to articulate with non-statisticians to interpret and explain statistical findings.
  • Excellent organizational and problem-solving skills.
  • Proven leadership skills and must work effectively in a team environment.
  • Knowledge of good biometrics procedures is desired.

Actual salary at the time of hire may vary and may be above or below the range based on various factors, including, but not limited to, the candidate’s relevant qualifications, skills, and experience, as well as the service line and location where this position may be filled.Salary Pay Range$365,000 - $403,000USDOur employees come from different backgrounds, and we celebrate those differences. We are looking for the best candidates for our open roles, but do not expect applicants to meet every qualification in order to be considered.

If you are excited about what you could accomplish at Cytokinetics and believe you can add value to our team, we would love to hear from you.

Please review our General Data Protection Regulation (GDPR) policy PRIOR to applying.  


Our passion is anchored in robust scientific thinking, grounded in integrity and critical thinking. We keep the patient front and center in all we do – all actions and decisions are in service of the patient and their caregivers. We champion integrity, ethics, doing the right thing, and being our best selves.

Fraud Warning: How to Identify Impersonated Cytokinetics Job Postings and Offers


Recently, there have been fraudulent employment offers being sent to candidates on behalf of Cytokinetics. Please be advised that all legitimate offers from Cytokinetics will come directly from our official email domain (Cytokinetics.com) and will only be made after completing a formal interview process.Here are some ways to check for authenticity:

  • We do not conduct job interviews through non-standard text messaging applications
  • We will never request personal information such as banking details until after an official offer has been accepted and verified
  • We will never request that you purchase equipment or other items when interviewing or hiring
  • If you are unsure about the authenticity of an offer, or if you receive any suspicious communication, please contact us directly at talentacquisition@cytokinetics.com

Please visit our website at: www.cytokinetics.com


Cytokinetics is an Equal Opportunity Employer



Life at Cytokinetics

We are a leading biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule drugs that specifically target the cytoskeleton. The cytoskeleton is a complex biological infrastructure that plays a fundamental role within every human cell. A number of commonly used drugs and a growing body of research validate the role that the cytoskeleton plays in a wide array of human diseases. Our focus on the cytoskeleton enables us to develop novel and potentially safer and more effective classes of drugs directed at treatments for cancer, cardiovascular disease, fungal diseases and other diseases. We have developed a cell biology driven approach and proprietary technologies to evaluate the function of many interacting proteins in the complex environment of the intact human cell. We believe that our approach enhances the speed, efficiency and yield of our drug discovery and development process by accurately and rapidly identifying drug candidates with attractive properties. Our approach has yielded two drug candidates for the treatment of cancer, a drug candidate for the treatment of acute congestive heart failure and more than ten other research programs. Our most advanced drug candidate, SB-715992, is the subject of a broad Phase II clinical trials program designed to evaluate its effectiveness in many different types of cancer. An investigational new drug application, or IND, was filed with the U.S. Food and Drug Administration, or FDA, in 2003 for our second cancer drug candidate, SB-743921, which we expect will enter Phase I clinical development in early 2004. SB-715992 and SB-743921 are being developed through our strategic alliance with GlaxoSmithKline. In addition, we expect to initiate Phase I clinical development for a drug candidate, CK-1213296, for the treatment of acute congestive heart failure in the second half of 2004.
Thrive Here & What We Value1. Passionate about robust scientific thinking grounded in integrity and critical thinking2. Celebrates differences among employees3. Patient-centric approach to all actions and decisions4. Values integrity, ethics, doing the right thing, and being our best selves5. Emphasis on patient-centered care6. Focus on innovation and continuous improvement7. Dedicated to keeping the patient front and center in all actions and decisions8. Values-driven and sustainable approach to drug discovery and development9. Rigorous scientific thinking and critical thinking10. Emphasis on collaboration across different departments and teams
Your tracker settings

We use cookies and similar methods to recognize visitors and remember their preferences. We also use them to measure ad campaign effectiveness, target ads and analyze site traffic. To learn more about these methods, including how to disable them, view our Cookie Policy or Privacy Policy.

By tapping `Accept`, you consent to the use of these methods by us and third parties. You can always change your tracker preferences by visiting our Cookie Policy.

logo innerThatStartupJob
Discover the best startup and their job positions, all in one place.
Copyright © 2024